Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3125151
Max Phase: Preclinical
Molecular Formula: C15H19N3O5
Molecular Weight: 321.33
Molecule Type: Small molecule
Associated Items:
ID: ALA3125151
Max Phase: Preclinical
Molecular Formula: C15H19N3O5
Molecular Weight: 321.33
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCOC(=O)c1nnn(-c2ccccc2)c1[C@H](O)[C@@H](O)[C@H](C)O
Standard InChI: InChI=1S/C15H19N3O5/c1-3-23-15(22)11-12(14(21)13(20)9(2)19)18(17-16-11)10-7-5-4-6-8-10/h4-9,13-14,19-21H,3H2,1-2H3/t9-,13-,14-/m0/s1
Standard InChI Key: KXYBHXXUHKZGGM-HERUPUMHSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 321.33 | Molecular Weight (Monoisotopic): 321.1325 | AlogP: 0.22 | #Rotatable Bonds: 6 |
Polar Surface Area: 117.70 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 12.25 | CX Basic pKa: | CX LogP: 0.53 | CX LogD: 0.53 |
Aromatic Rings: 2 | Heavy Atoms: 23 | QED Weighted: 0.65 | Np Likeness Score: -0.95 |
1. Putapatri SR, Kanwal A, Banerjee SK, Kantevari S.. (2014) Synthesis of novel l-rhamnose derived acyclic C-nucleosides with substituted 1,2,3-triazole core as potent sodium-glucose co-transporter (SGLT) inhibitors., 24 (6): [PMID:24556379] [10.1016/j.bmcl.2014.01.077] |
Source(1):